In this study, the prevalence of human papillomavirus integration in cervical intraepithelial neoplasia Grades I, II, and III has been investigated using a highly sensitive biotinyl-tyramide-based in situ hybridization methodology. This method is able to demonstrate integrated viral DNA by punctate signals within the nucleus and episomal viral DNA by a diffuse signal throughout the nucleus. 
Human papillomaviruses (HPV) are recognized as a necessary cause of cervical intraepithelial neoplasia (CIN; 1), however only a minority of HPV infections ever results in a CIN lesion (2) . Although the majority of infections may be cleared by the immune system, much remains to be understood about how persistent infections give rise to lesions of different histological grade and how CIN lesions evolve. It is also unclear why certain high-risk HPV types are significantly more common among high-grade lesions and carcinomas than other high-risk HPV types.
One factor that may be important in CIN progression is integration of HPV sequences into the cell genome. In cell lines and carcinomas, integration has been found to involve disruption and loss of function of the E2 gene that is responsible for regulating expression of the E6 and E7 oncogenes (3) . Unregulated high-risk HPV-type E7 expression confers a selective growth advantage on cells in vitro (4) , and high-risk E6 and E7 gene expression is associated with loss of cell cycle control and aberrant centrosome function (5, 6) . Such defects may predispose to the accumulation of genetic anomalies promoting the development of the invasive phenotype (7) .
Nonisotopic in situ hybridization has previously been established as a method for the demonstra-tion of integrated HPV sequences. Signal patterns were found to match HPV physical status, as determined by analysis of restriction digest patterns/ two-dimensional gel electrophoresis of HPV DNA extracted from cervical tissues (8 -10) . A discrete, punctate signal pattern within a cell nucleus correlated with integration, whereas a diffuse signal throughout the nucleus indicated episomal HPV. However, until recently, nonisotopic in situ hybridization methodologies have been limited by lack of sensitivity to demonstrate low-copy number integrated HPV sequences.
In this study, a biotinyl-tyramide-based in situ amplification methodology was optimized to enable the reproducible detection of one to two integrated copies of the HPV genome in a model cell line. The aims of the study were to examine the presence of HPV DNA integration in lesions of different pathologic grade and infected with different HPV types and to determine the extent to which in situ hybridization signal patterns distinguish lowand high-grade lesions.
MATERIALS AND METHODS

Samples
Twenty-eight CIN I (4 condylomatous) and 22  CIN II/III (9 CIN II, 3 CIN II/III, 10 CIN III) formalin-fixed, paraffin-embedded tissue specimens were obtained from the Fletcher Allen Health Care pathology archives.
DNA Extraction
For each specimen, three 10-m sections were cut into tubes, dewaxed with xylene, washed with ethanol, and allowed to dry. After overnight digestion at 55°C with 400 g/mL of proteinase K (Life Technologies) in 200 -400 L of 50 mM Tris-HCl, pH 8.0, tissue debris was pelleted by centrifugation, and the supernatant was used directly for PCR amplification.
PCR of HPV Sequences
HPV sequences were demonstrated by a modification of the General Primer 5ϩ/6ϩ PCR assay (11) . A 50-L reaction comprised 2-25 L of DNA extract, 1ϫ PCR reaction buffer (Qiagen), 4 mM of MgCl 2 , 1ϫ ACGU dNTP mix (Sigma), 1 mM GP5ϩ primer (5'-TTTGTTACTGTGGTAGATACTAC-3'), 1 mM GP6ϩ primer (5'-GAAAAATAAACTGTAAATCATATTC-3'), 1 U HotStar Taq DNA polymerase (Qiagen), and 0.2 U of HK™-Thermolabile Uracil N-Glycosylase (Epicentre). PCR cycles comprised a 30-minute incubation at 37°C to enable Uracil N-Glycosylase function; 15 minutes at 95°C to inactivate Uracil N-Glycosylase and activate the HotStar Taq; and 40 cycles of 1 minute at 94.5°C, 2 minutes at 40°C, and 1.5 minutes at 72°C. A 5-minute incubation at 72°C completed the PCR. Observation of an~150 -base pair PCR product after electrophoresis through 2.5% agarose gel was taken as evidence of HPV positivity.
Determination of HPV Type
Two microliters of heat-denatured PCR product was spotted onto a nylon membrane, baked at 80°C for 2 hours, ultraviolet fixed by Stratalinker (Stratagene), and prehybridized at 55°C for 2 hours with 2ϫ SSC, 0.1% lauryl sarcosine, 0.02% SDS, and 1% blocking reagent (Roche Diagnostics). Membranes were hybridized overnight with 20 pmol/mL biotinlabeled HPV type-specific oligonucleotides. Oligoprobes to 22 HPV types were used in this study (HPV types 6, 11, 16, 18, 31, 33-35, 39, 40, 42-45, 51, 52, 54, 56, 58, 59, 66, and 68; 11). Membranes were washed at 55°C in 2ϫ SSC, 0.1% SDS three times for 10 minutes, then blocked at 20°C in 100 mM TrisHCl, pH 8.0; 100 mM NaCl; and 1% blocking reagent for 1.5 hours, and the biotin label was demonstrated using the BluGene detection system (Life Technologies).
In Situ Hybridization
In situ hybridization was performed using individual plasmid probes (for Types 6*, 11, 16, 18*, 31*, 33, 35*, 43*, 56*; *American Tissue Culture Collection) labeled with biotin by nick translation (Life Technologies). A wide spectrum HPV probe (DAKO) was used in cases for which the specific probe was not available.
The GenPoint Catalyzed Signal Amplification System (DAKO) was optimized for reproducible sensitive and background free usage. Formalinfixed, paraffin-embedded SiHa cells that contain one to two copies of HPV 16 integrated at chromosome 13q, HeLa cells that contain Յ50 HPV 18 copies integrated at five sites and CaSki cells that contain Յ600 HPV 16 copies integrated at multiple sites, and carcinoma tissues were used as model systems (12) .
Tissue sections 6 m thick were cut onto ADCELL slides (Erie Scientific Company) and dried overnight at 55°C. Tissues were dewaxed in two 5-minute changes of xylene followed by graded (100 -70%) ethanol washes. After rinsing in water, tissues were air dried and then immersed for 40 minutes in a Coplin jar containing 10 mM sodium citrate, pH 6.0, pre-equilibrated to temperature in a water bath set at 95.0°C. The Coplin jar was then removed from the water bath and allowed to cool at room temperature for 20 minutes. The slides were rinsed with water and air dried. Tissues were then digested at 25°C with 100 g/mL pepsin (Sigma P-7012) in 0.2 M HCl. Digestion times were optimized for each sample and ranged from 5 to 45 minutes, with 20 minutes being most typically optimal. Slides were rinsed three times for 5 minutes each in PBS (0.01 M phosphate, 0.027 M KCl, 0.137 M NaCl, pH 7.4) and 0.05% Tween 20, followed by three 5-minute rinses in PBS and water and air drying.
Hybridization mixture was applied directly to the tissue section and comprised 50% formamide; 10% dextran sulfate; 2ϫ SSC, pH 7.0; 400 ng/L sonicated human placental DNA (Sigma); and 2 ng/L HPV probe. Coverslipped slides were placed into Terasaki plates (Nunc) containing 5ϫ SSC. The plates were laid onto a 1.5-cm-thick aluminium plate in an oven set at 95°C for 15 minutes to enable simultaneous denaturation of probe and target sequences. Biotinylated plasmid probe (pUC) was used as a negative control. Tissues were hybridized overnight at 37°C. Coverslips were removed by rinsing the slides in 300 mM NaCl; 50 mM Tris-HCl, pH 7.6; and 0.05% Tween 20. Samples were washed at high stringency (0.1ϫ SSC at 55°C, twice for 10 min), or low stringency (2ϫ SSC at 37°C, twice for 10 min) when the wide-spectrum probe was used.
Detection of biotin was performed according to the GenPoint protocol replacing diaminobenzidine chromogen with aminoethylcarbazole. Primary streptavidin horseradish-peroxidase conjugate used at a dilution of 1:500 was found sufficient to demonstrate the integrated HPV copies in the SiHa, HeLa, and CaSki cell preparations and carcinomas and so was used as the standard dilution (Fig. 1A) . Dilutions as low as 1:5000 were also used to confirm that diffuse signal did not represent coalescence of signals from HPV integrated at high copy number. Biotinyl-tyramide and secondary streptavidinhorseradish peroxidase conjugate were used as supplied in the GenPoint kit. Aminoethylcarbazole (Sigma) was applied to sections for 10 minutes. Sections were counterstained with hematoxylin and mounted in glycerol gelatin (Sigma).
Statistics
For analytical purposes, CIN II and III samples were combined as one group. Fisher's exact test and odds ratio (OR) with 95% confidence intervals (CI) were performed using software supplied by GraphPad InStat (San Diego, CA).
RESULTS
HPV Type
The data from this study are summarized in Tables 1 and 2. A total of 15 HPV types was identified using the panel of 22 oligonucleotide probes. Fourteen types were positively identified among the CIN I samples, and 7 among the CIN II/III. PCR products that could not be specifically typed with the oligonucleotide panel were obtained from two CIN I lesions.
Classifying HPV types into low-risk types (e.g. Of the five high-risk positive CIN I lesions demonstrating punctate signals, two were HPV 16 positive. Approximately 30% of cells demonstrating in situ hybridization signals contained punctate signal, and these two were the only CIN I lesions in which basal punctate signal was detected (Fig. 1C) . In the three other punctate-diffuse high-risk positive CIN I samples, punctate signals were present in Ͻ5% of cells and were restricted to occasional cells in the superficial layer (Fig. 1D) .
One CIN I (HPV 45-positive) tissue block retrieved from archives contained three separate pieces of biopsied tissue. Morphologically defined CIN I was present on two pieces. Only intense diffuse staining was demonstrated, and this was confined to the mid-to superficial layers (Fig. 1E) . The third tissue piece, which was morphologically normal by review of preceding and subsequent hematoxylin and eosin-stained sections as well as review of in situ hybridization-processed tissues, also demonstrated diffuse signal (Fig. 1F) .
CIN I lesions ranged in size from Ͻ1 high-power (400ϫ) field (HPV 43 positive) to 7.5 mm in length (HPV 45 positive). HPV DNA was detectable by biotinyl-tyramidebased in situ hybridization at all levels of the epithelium, including the basal and parabasal layers in all but two CIN II specimens (one HPV 45-positive, one focal HPV 58 -positive lesion). Intense diffuse signals either were present in the middle and parabasal regions (Fig. 2B) or were confined to the superficial layers (Fig. 2C) . Punctate and diffuse signals were in all cases distributed across the entire lesion. There was no evidence of emergent foci of diffuse-punctate or punctate-only signals arising within a lesion that otherwise demonstrated a diffuse-only signal pattern across its length. There was heterogeneity across large CIN II/III lesions with respect to proportion of punctate to diffuse cell signals and depth within epithelium at which diffuse signals were detectable. One lesion demonstrated punctate and diffuse signals for most of its length but also included a region of punctate-only signals (Fig. 2C-D) . Cell-to-cell heterogeneity was also evident, with intense diffuse cells being found directly adjacent to punctate cells in superficial layers (Fig. 2C) . CIN II/III lesions ranged in size from Ͻ1 high-power (400ϫ) field (HPV 45-and HPV 58 -positive) to 1.5 cm in length (HPV 16 -positive) .
CIN II/III
In addition to SiHa cells, punctate signals were readily detectable in CaSki and HeLa cell preparations as well as in carcinoma samples, and specimens probed with biotinylated pUC demonstrated no signal (data not shown).
DISCUSSION
The major finding of this study is that biotinyltyramide-based in situ hybridization signal patterns distinguish HPV 16 from other HPV types and also distinguish CIN I from CIN II/III lesions. Punctate signals were invariably detectable in the basal layers of HPV 16 -positive CIN I or CIN II/III lesions. Other HPV types demonstrated basal signals only in CIN II/III lesions ( Fig. 2A-F) . Punctate signals were rare and confined to occasional superficial cells in high-risk HPV (non-HPV 16 positive) infected CIN I lesions but were common when these types were found among CIN II/III tissues. These findings have implications for understanding HPV integration, significance of HPV type, and CIN progression.
HPV and Integration
This study has demonstrated that HPV DNA integrated into the cell genome is detectable as punctate signals by biotinyl-tyramide-based in situ hybridization (Fig. 1A) . Application of this technique to 50 CIN lesions suggests that the presence of integration is a defining feature of CIN II/III. This finding is in agreement with previous estimates of integration prevalence among CIN II/III lesions (13) (14) (15) . It is also in agreement with analyses of HPV DNA open-reading frame transcription patterns obtained after in situ hybridization assay with radiolabeled riboprobes. Stoler et al. (16) found that 15 of 16 (94%) HPV 16 -infected CIN III lesions demonstrated open-reading frame transcription patterns that were consistent with the presence of both episomal and integrated HPV DNA. Two HPV 18 -positive CIN III tissues examined in the same study both demonstrated transcription patterns consistent with the presence of integrated sequences alone. However, the data contrast with other estimates that integration is found in 5-50% of CIN II/III lesions (17) (18) (19) (20) (21) . Technical difficulties may account for the contradictory findings. Previous estimates of integration have required fresh tissue specimens for analysis. Patient diagnostic requirements permit only limited quantities of unfixed tissues for experimental analysis. Sensitivity is therefore a key issue, with the detection of integration depending on the quantity and quality of nucleic acid available for analysis. As noted by Cullen et al. (18) , concomitant episomal forms can mask the presence of relatively small amounts of integrated HPV DNA. An RT-PCR assay based on the finding that HPV RNA integrate-derived transcripts contain host cellular sequences was designed to detect integrated HPV sequences in the presence of episomal HPV (21) . Nevertheless, the method is still dependent on threshold levels of target RNA in the sample tissue analyzed. All of these techniques presuppose that CIN lesions are relatively homogenous with respect to integration status. In situ hybridization allows direct cell-by-cell visualization of events by light microscopy. Thus, the presence of HPV DNA integration in a minority of cells within a lesion is potentially measurable, and the technique is not subject to the sensitivity limitations of other methodologies. Punctate signals were detectable in tissues demonstrating intense and abundant diffuse signals (Fig. 2B-C ) that were consistent with the underestimation of integration levels because of episomal masking (18) . The findings of the present study suggest that low-risk HPV type DNA can also become integrated into the cell genome. These lesions were low grade, in line with the oncogenic character of these HPV types (3) . Further investigation is required of this finding and also of the significance of basalcompared with mid-or superficial-layer punctate signals. Integration may occur in the basal layer through disruption of constitutive cell cycle control, and/or integration can also be initiated in other epithelial layers through disruption of differentiation-maturation control pathways.
Punctate signal has been interpreted in this study as evidence of integration. All available experimental precedents (e.g. correlation of signal patterns with Southern blot assays and in situ hybridization of cell lines) indicate that punctate signals represent integration of viral DNA into the cell genome. It is also possible to accommodate this interpretation with previous studies of integration as detailed above. Moreover, punctate signals were found associated with increasing pathologic grade of cervical lesion, and this is also readily explainable by accepting punctate signals to be representative of integration. However, it cannot be stated categorically that every punctate signal represents integration. Further confirmation of this interpretation is required, as several issues require clarification.
Primary HPV infection is understood to occur in the basal and parabasal layers of the cervical epithelium, and productive viral replication is linked to epithelial differentiation, which takes place in the mid and superficial layers (3; Figs. 1E and 2E ). The absence of in situ hybridization signals in the basal and parabasal layers of CIN I lesions (other than those infected with HPV 16) has been interpreted in this study as failure of the biotinyltyramide assay to detect low-copy number HPV when in the form of~8 kilo-base pair episomes, as they may represent too scattered a target. In contrast it is suggested that HPV, when physically integrated into the host-cell chromosomes, is detectable at low-copy number, as the DNA is then a relatively more concentrated target. Absence of punctate or diffuse signal in every cell within a lesion is accounted for in terms of loss of low-copy number target DNA because of tissue sectioning. In addition, clarification is required of the speculation that low-copy number HPV concatamers comprising compounded multiple units of the HPV genome may also be represented by punctate signals.
There are no model systems available that contain low-copy,~8 kilobase episomal or concatameric HPV molecules to examine these issues. Resolution of such uncertainties may be possible by combining biotinyl-tyramide-based in situ hybridization with electron microscopy and/or confocal microscopy techniques on pathology samples. PCR analysis of (laser-capture) microdissected epithelial layers may also assist in physical status assessment.
HPV Type and CIN Grade
HPV 16 was the most frequently identified type among CIN II/III tissues, in agreement with results of previous studies (22) . The significantly uneven distribution of HPV 16 prevalence between CIN grades supports the contention that CIN II/III lesions can arise de novo (23) and/or that HPV 16 -infected CIN I may rapidly progress to high grade. For example, a longitudinal study of young women who had recently become sexually active found that the risk of CIN III was greatest in those who tested positive for HPV 16 and that this risk was maximum just 6 -12 months after first detection of HPV 16 (24) .
CIN Progression
The data from this study support a hypothesis that HPV 16 DNA may readily integrate into the cell genome. Disruption of the E2 open-reading frame and unregulated E6/E7 activity may then explain the common association of HPV 16 and not other high-risk HPV types with high-grade lesions and invasive disease, as well as the uneven distribution of HPV 16 between CIN grades. Further, punctate signals were rare among CIN I lesions infected with non-HPV 16 high-risk types, but common when these types were associated with CIN II/III tissues ( Fig. 2E-F) . This finding suggests that acquisition of the punctate correlate, especially in the basal layer, is critical for the development of a high-grade lesion.
Acquisition of the punctate signal correlate is also indicated as occurring early in CIN II/III development because there was no evidence of incipient punctate or of punctate-diffuse foci arising within a diffuse-classified CIN II/III lesion. In addition, focal CIN II/III tissues demonstrated punctate signals, suggesting that they arose de novo and not via progression from diffuse (episomal) states. This concept is also supported by the demonstration that CIN II/III lesions associated with high-risk types have a monoclonal origin (25) . Secondary clonal expansions may subsequently give rise to punctatediffuse signal type heterogeneity and other forms of intralesional heterogeneity, such as allelic imbalance (26) . A high prevalence of integration in CIN II/III lesions is consistent with the development of invasive capacity, depending not on integration per se (which may of itself support cell proliferation; 4) but on the (stochastic) acquisition of key genetic defects (7) subsequent to loss of E6/E7 regulation.
The demonstration of high-risk HPV in histologically normal tissue is, to the authors' knowledge, the first by in situ hybridization and supports the report of high-risk HPV in cytologically normal samples (11) . Further study of the prevalence of such diffuse signal (episomal HPV) in "normal" female (and male) tissues and of the relationship to progression to recognizable CIN is required.
In summary, biotinyl-tyramide-based in situ hybridization is an emerging technology that allows sensitive direct visualization of HPV at the lightmicroscopic level. Although larger studies are needed, the data from this study demonstrate the potential of the technique to provide an increased understanding of cervical intraepithelial neoplasia.
